EyePoint Drug Trial Flop Crashes Stock. Can a Strategy Shift Save It? EyePoint Drug Trial Flop Crashes Stock. Can a Strategy Shift Save It? · Barrons.com · Dreamstime Mariapaula Gonzalez October 19, 2026 2 min read EYPT -8.32% The stock stock is heading for its largest single-day percentage drop on record. Continue Reading Terms and Privacy Policy Your Privacy Choices More Info